Your browser doesn't support javascript.
loading
Hypoxic Memory Mediates Prolonged Tumor-Intrinsic Type I Interferon Suppression to Promote Breast Cancer Progression.
Iriondo, Oihana; Mecenas, Desirea; Li, Yilin; Chin, Christopher R; Thomas, Amal; Moriarty, Aidan; Marker, Rebecca; Wang, Yiru J; Hendrick, Haley; Amzaleg, Yonatan; Ortiz, Veronica; MacKay, Matthew; Dickerson, Amber; Lee, Grace; Harotoonian, Sevana; Benayoun, Bérénice A; Smith, Andrew; Mason, Christopher E; Roussos Torres, Evanthia T; Klotz, Remi; Yu, Min.
Afiliação
  • Iriondo O; Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California.
  • Mecenas D; USC Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, California.
  • Li Y; Center for Cooperative Research (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Chin CR; Ikerbasque, Basque Foundation for Science, Bilbao, Spain.
  • Thomas A; Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California.
  • Moriarty A; USC Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, California.
  • Marker R; Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California.
  • Wang YJ; USC Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, California.
  • Hendrick H; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
  • Amzaleg Y; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York.
  • Ortiz V; Department of Molecular and Computational Biology, USC Dana and David Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, California.
  • MacKay M; Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California.
  • Dickerson A; Department of Pharmacology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Lee G; Marlene and Stewart Greenebaum NCI Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
  • Harotoonian S; Department of Pharmacology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Benayoun BA; Marlene and Stewart Greenebaum NCI Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
  • Smith A; Department of Pharmacology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Mason CE; Marlene and Stewart Greenebaum NCI Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
  • Roussos Torres ET; Department of Pharmacology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Klotz R; Marlene and Stewart Greenebaum NCI Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.
  • Yu M; Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California.
Cancer Res ; 84(19): 3141-3157, 2024 Oct 01.
Article em En | MEDLINE | ID: mdl-38990731
ABSTRACT
Hypoxia is a common feature of many solid tumors due to aberrant proliferation and angiogenesis that is associated with tumor progression and metastasis. Most of the well-known hypoxia effects are mediated through hypoxia-inducible factors (HIF). Identification of the long-lasting effects of hypoxia beyond the immediate HIF-induced alterations could provide a better understanding of hypoxia-driven metastasis and potential strategies to circumvent it. Here, we uncovered a hypoxia-induced mechanism that exerts a prolonged effect to promote metastasis. In breast cancer patient-derived circulating tumor cell lines and common breast cancer cell lines, hypoxia downregulated tumor-intrinsic type I IFN signaling and its downstream antigen presentation (AP) machinery in luminal breast cancer cells, via both HIF-dependent and HIF-independent mechanisms. Hypoxia induced durable IFN/AP suppression in certain cell types that was sustained after returning to normoxic conditions, presenting a "hypoxic memory" phenotype. Hypoxic memory of IFN/AP downregulation was established by specific hypoxic priming, and cells with hypoxic memory had an enhanced ability for tumorigenesis and metastasis. Overexpression of IRF3 enhanced IFN signaling and reduced tumor growth in normoxic, but not hypoxic, conditions. The histone deacetylase inhibitor entinostat upregulated IFN targets and erased the hypoxic memory. These results point to a mechanism by which hypoxia facilitates tumor progression through a long-lasting memory that provides advantages for circulating tumor cells during the metastatic cascade.

Significance:

Long-term cellular memory of hypoxia leads to sustained suppression of tumor-intrinsic type I IFN signaling and the antigen presentation pathway that facilitates tumorigenesis and metastasis. See related commentary by Purdy and Ford, p. 3125.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Interferon Tipo I / Progressão da Doença Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Interferon Tipo I / Progressão da Doença Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2024 Tipo de documento: Article
...